Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Oct;4(10):823-7.
doi: 10.1002/alr.21366. Epub 2014 Sep 11.

Endoscopic sinus surgery compared to continued medical therapy for patients with refractory chronic rhinosinusitis

Kristine A Smith  1 , Timothy L Smith, Jess C Mace, Luke Rudmik
Affiliations
Clinical Trial

Endoscopic sinus surgery compared to continued medical therapy for patients with refractory chronic rhinosinusitis

Kristine A Smith et al. Int Forum Allergy Rhinol. 2014 Oct.

Abstract

Background: The decision to continue medical therapy or recommend endoscopic sinus surgery (ESS) can be challenging in patients with refractory chronic rhinosinusitis (CRS). The objective of this study was to evaluate continued medical therapy vs ESS for patients with refractory CRS who have severe reductions in baseline disease-specific quality of life (QoL).

Methods: This was a prospective longitudinal crossover study between August 2011 and June 2013. All patients were >18 years old, diagnosed with CRS based on guideline recommendations, failed initial medical therapy and elected ESS. While waiting for ESS, all patients received continued medical therapy. The preoperative waiting period outcomes (continued medical therapy) were compared to the postoperative outcomes. The primary outcome was change in disease-specific QoL (22-item Sinonasal Outcome Test [SNOT-22]). Secondary outcomes were change in endoscopic grading (Lund-Kennedy score), medication consumption, and work days missed in the preceding 90 days.

Results: Thirty-one patients were enrolled. Mean baseline SNOT-22 score was 57.6. After a mean of 7.1 months of continued medical therapy, there was a worsening in SNOT-22 score (57.6 to 66.1; p = 0.006). After ESS, with a mean postoperative follow-up of 14.6 months, there was a significant improvement in SNOT-22 score (66.1 to 16.0; p < 0.001). There was also a significant improvement in endoscopic grading (p < 0.001) coupled with a reduction in both work days lost (p < 0.001) and medication consumption (p < 0.01).

Conclusion: Results from the study suggest that ESS is a more effective intervention compared to continued medical therapy for patients with refractory CRS who have severe reductions in their baseline disease-specific QoL.

Trial registration: ClinicalTrials.gov NCT01332136.

Keywords: chronic rhinosinusitis; endoscopic sinus surgery; medical therapy; quality of life; sinusitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flow diagram outlining data collection time points
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Soler ZM, et al. Patient-centered decision making in the treatment of chronic rhinosinusitis. Laryngoscope. 2013;123(10):2341–6. - PMC - PubMed
    1. Smith TL, et al. Medical therapy vs surgery for chronic rhinosinusitis: a prospective, multi-institutional study. Int Forum Allergy Rhinol. 2011;1(4):235–41. - PubMed
    1. Smith KA, Rudmik L. Impact of continued medical therapy in patients with refractory chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014;4(1):34–8. - PubMed
    1. Rosenfeld RM. Clinical practice guideline on adult sinusitis. Otolaryngol Head Neck Surg. 2007;137(3):365–77. - PubMed
    1. Soler ZM, et al. Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendations. Int Forum Allergy Rhinol. 2013;3(1):31–47. - PubMed

Publication types

MeSH terms

Substances

Associated data